1. Home
  2. IPSC vs OPHC Comparison

IPSC vs OPHC Comparison

Compare IPSC & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • OPHC
  • Stock Information
  • Founded
  • IPSC 2019
  • OPHC 2000
  • Country
  • IPSC United States
  • OPHC United States
  • Employees
  • IPSC N/A
  • OPHC N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • OPHC Major Banks
  • Sector
  • IPSC Health Care
  • OPHC Finance
  • Exchange
  • IPSC Nasdaq
  • OPHC Nasdaq
  • Market Cap
  • IPSC 48.2M
  • OPHC 43.1M
  • IPO Year
  • IPSC 2021
  • OPHC N/A
  • Fundamental
  • Price
  • IPSC $0.53
  • OPHC $4.40
  • Analyst Decision
  • IPSC Strong Buy
  • OPHC
  • Analyst Count
  • IPSC 5
  • OPHC 0
  • Target Price
  • IPSC $3.33
  • OPHC N/A
  • AVG Volume (30 Days)
  • IPSC 719.1K
  • OPHC 20.2K
  • Earning Date
  • IPSC 05-15-2025
  • OPHC 05-12-2025
  • Dividend Yield
  • IPSC N/A
  • OPHC N/A
  • EPS Growth
  • IPSC N/A
  • OPHC 30.24
  • EPS
  • IPSC N/A
  • OPHC 1.33
  • Revenue
  • IPSC $114,898,000.00
  • OPHC $39,980,000.00
  • Revenue This Year
  • IPSC $833.10
  • OPHC N/A
  • Revenue Next Year
  • IPSC N/A
  • OPHC N/A
  • P/E Ratio
  • IPSC N/A
  • OPHC $3.30
  • Revenue Growth
  • IPSC 8286.72
  • OPHC 53.28
  • 52 Week Low
  • IPSC $0.34
  • OPHC $3.53
  • 52 Week High
  • IPSC $3.46
  • OPHC $5.90
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 46.73
  • OPHC 49.09
  • Support Level
  • IPSC $0.48
  • OPHC $4.36
  • Resistance Level
  • IPSC $0.59
  • OPHC $4.52
  • Average True Range (ATR)
  • IPSC 0.04
  • OPHC 0.09
  • MACD
  • IPSC -0.00
  • OPHC -0.03
  • Stochastic Oscillator
  • IPSC 34.62
  • OPHC 9.52

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About OPHC OptimumBank Holdings Inc.

OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides a range of community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal account, money market deposit accounts, debit cards, and automated teller machines.

Share on Social Networks: